Table.

Events of VTE Observed Across Treatment Groups

UPA 15 mg QDa
N=2629
(4565.8 PYs)
UPA 30 mg QDb
N=1204
(2309.7 PYs)
ADA + MTXc
N=579
(768.6 PYs)
MTX Monotherapyd
N=314
(456.0 PYs)
Events, n21842
Patients, n20742
PE only11131
DVT only5210
PE + DVT4401
  • aFrom SELECT-EARLY, -MONOTHERAPY, -NEXT, -COMPARE, and -BEYOND.

  • bFrom SELECT-EARLY, -MONOTHERAPY, -NEXT, and -BEYOND.

  • cFrom SELECT-COMPARE.

  • dFrom SELECT-EARLY.

  • VTE, venous thromboembolism; PE, pulmonary embolism; DVT, deep vein thrombosis.